AI in Drug Discovery Market Size, Share, and Outlook, H2-2025 Report- By Offering (Software, Services), By Technology (Machine Learning, Natural Language Processing, Context-aware Processing, Others), By Therapeutic Area (Oncology, Infectious Diseases, Ne
Description
AI in Drug Discovery Market Outlook
The global AI in Drug Discovery Market Size is valued at $2.4 Billion in 2025 and is forecast to reach $12.4 Billion in 2032 at a CAGR of 26.5%.
The AI in Drug Discovery Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on AI in Drug Discovery Market segments across 22 countries from 2021 to 2032. Key segments covered include By Offering (Software, Services), By Technology (Machine Learning, Natural Language Processing, Context-aware Processing, Others), By Therapeutic Area (Oncology, Infectious Diseases, Neurology, Metabolic Diseases, Cardiovascular Diseases, Immunology, Others), By Process (Target Identification & Selection, Target Validation, Hit Identification & Prioritization, Hit-to-lead Identification/ Lead generation, Lead Optimization, Candidate Selection & Validation), By End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Research Centers and Academic & Government Institutes), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
AI in Drug Discovery Market Insights, 2025
AI in drug discovery is transforming pharmaceutical R&D by enabling rapid identification of potential drug candidates, predicting molecular interactions, and optimizing clinical trial design. Recent breakthroughs include deep learning models that analyze large biomedical datasets to uncover novel targets and repurpose existing drugs. Integration of AI with high-throughput screening and cheminformatics enhances efficiency and reduces costs. AI-driven simulations and predictive analytics accelerate lead optimization and toxicity profiling. Regulatory bodies are evolving frameworks to validate AI models within drug development pipelines. Partnerships between AI startups and pharmaceutical giants are expanding, fostering innovation. Ethical considerations around data privacy and algorithm transparency are under active discussion. The convergence of AI with genomics and personalized medicine drives the next frontier in drug discovery.
Five Trends Shaping the Global AI in Drug Discovery Market in 2025 and Beyond
The global AI in Drug Discovery Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the AI in Drug Discovery Industry?
The AI in Drug Discovery Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, AI in Drug Discovery Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
AI in Drug Discovery Market Segment Insights
The AI in Drug Discovery Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Offering (Software, Services), By Technology (Machine Learning, Natural Language Processing, Context-aware Processing, Others), By Therapeutic Area (Oncology, Infectious Diseases, Neurology, Metabolic Diseases, Cardiovascular Diseases, Immunology, Others), By Process (Target Identification & Selection, Target Validation, Hit Identification & Prioritization, Hit-to-lead Identification/ Lead generation, Lead Optimization, Candidate Selection & Validation), By End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Research Centers and Academic & Government Institutes). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
AI in Drug Discovery Industry Value Chain
The chapter identifies potential companies and their operations across the global AI in Drug Discovery Industry ecosystem. It assists decision-makers in evaluating global AI in Drug Discovery Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the AI in Drug Discovery Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific AI in Drug Discovery Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for AI in Drug Discovery Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States AI in Drug Discovery Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American AI in Drug Discovery Market.
Europe AI in Drug Discovery Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for AI in Drug Discovery Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for AI in Drug Discovery Industry competitiveness. The report analyses the key AI in Drug Discovery Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American AI in Drug Discovery Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international AI in Drug Discovery Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa AI in Drug Discovery Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for AI in Drug Discovery Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How AI in Drug Discovery Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the AI in Drug Discovery Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes Aria Pharmaceuticals Inc, Atomwise Inc, BenevolentAI Ltd, Celsius Therapeutics Inc, Cloud Pharmaceuticals Inc, Deep Genomics Inc, Envisagenics Inc, Exscientia Ltd, Google LLC, Illumina Inc, Insilico Medicine Inc, IQVIA Holdings Inc, Microsoft Corp, NVIDIA Corp, Predictive Oncology Inc, Recursion Pharmaceuticals Inc, Schrödinger Inc, Tempus Labs Inc, Tencent Holdings Ltd, Valo Health LLC, Verge Genomics Inc. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
AI in Drug Discovery Market Scope
Leading Segments
By Offering
Software
Services
By Technology
Machine LearningDeep Learning Supervised Learning Reinforcement Learning Others
Natural Language Processing
Context-aware Processing
Others
By Therapeutic Area
Oncology
Infectious Diseases
Neurology
Metabolic Diseases
Cardiovascular Diseases
Immunology
Others
By Process
Target Identification & Selection
Target Validation
Hit Identification & Prioritization
Hit-to-lead Identification/ Lead generation
Lead Optimization
Candidate Selection & Validation
By End-User
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Research Centers and Academic & Government Institutes
Leading Companies
Aria Pharmaceuticals Inc
Atomwise Inc
BenevolentAI Ltd
Celsius Therapeutics Inc
Cloud Pharmaceuticals Inc
Deep Genomics Inc
Envisagenics Inc
Exscientia Ltd
Google LLC
Illumina Inc
Insilico Medicine Inc
IQVIA Holdings Inc
Microsoft Corp
NVIDIA Corp
Predictive Oncology Inc
Recursion Pharmaceuticals Inc
Schrödinger Inc
Tempus Labs Inc
Tencent Holdings Ltd
Valo Health LLC
Verge Genomics Inc
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report Make informed decisions with 12-year forecasts across 22 countries and multiple market segments. Evaluate regulatory impacts, sustainability trends, and disruptive technologies shaping the chemicals industry. Gain insights into the competitive landscape, including company profiles, financials, and strategic moves. Build an integrated understanding of the chemicals ecosystem across upstream, midstream, and downstream operations. Leverage insights on circular economy initiatives, digitalization, and carbon-neutral strategies driving the next decade. Assess risks and opportunities with scenario-based forecasts tailored to different growth conditions. Access the report in multiple formats (PDF, Excel, PPT) for easier integration into strategic planning.
The global AI in Drug Discovery Market Size is valued at $2.4 Billion in 2025 and is forecast to reach $12.4 Billion in 2032 at a CAGR of 26.5%.
The AI in Drug Discovery Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on AI in Drug Discovery Market segments across 22 countries from 2021 to 2032. Key segments covered include By Offering (Software, Services), By Technology (Machine Learning, Natural Language Processing, Context-aware Processing, Others), By Therapeutic Area (Oncology, Infectious Diseases, Neurology, Metabolic Diseases, Cardiovascular Diseases, Immunology, Others), By Process (Target Identification & Selection, Target Validation, Hit Identification & Prioritization, Hit-to-lead Identification/ Lead generation, Lead Optimization, Candidate Selection & Validation), By End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Research Centers and Academic & Government Institutes), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
AI in Drug Discovery Market Insights, 2025
AI in drug discovery is transforming pharmaceutical R&D by enabling rapid identification of potential drug candidates, predicting molecular interactions, and optimizing clinical trial design. Recent breakthroughs include deep learning models that analyze large biomedical datasets to uncover novel targets and repurpose existing drugs. Integration of AI with high-throughput screening and cheminformatics enhances efficiency and reduces costs. AI-driven simulations and predictive analytics accelerate lead optimization and toxicity profiling. Regulatory bodies are evolving frameworks to validate AI models within drug development pipelines. Partnerships between AI startups and pharmaceutical giants are expanding, fostering innovation. Ethical considerations around data privacy and algorithm transparency are under active discussion. The convergence of AI with genomics and personalized medicine drives the next frontier in drug discovery.
Five Trends Shaping the Global AI in Drug Discovery Market in 2025 and Beyond
The global AI in Drug Discovery Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the AI in Drug Discovery Industry?
The AI in Drug Discovery Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, AI in Drug Discovery Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
AI in Drug Discovery Market Segment Insights
The AI in Drug Discovery Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Offering (Software, Services), By Technology (Machine Learning, Natural Language Processing, Context-aware Processing, Others), By Therapeutic Area (Oncology, Infectious Diseases, Neurology, Metabolic Diseases, Cardiovascular Diseases, Immunology, Others), By Process (Target Identification & Selection, Target Validation, Hit Identification & Prioritization, Hit-to-lead Identification/ Lead generation, Lead Optimization, Candidate Selection & Validation), By End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Research Centers and Academic & Government Institutes). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
AI in Drug Discovery Industry Value Chain
The chapter identifies potential companies and their operations across the global AI in Drug Discovery Industry ecosystem. It assists decision-makers in evaluating global AI in Drug Discovery Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the AI in Drug Discovery Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific AI in Drug Discovery Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for AI in Drug Discovery Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States AI in Drug Discovery Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American AI in Drug Discovery Market.
Europe AI in Drug Discovery Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for AI in Drug Discovery Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for AI in Drug Discovery Industry competitiveness. The report analyses the key AI in Drug Discovery Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American AI in Drug Discovery Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international AI in Drug Discovery Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa AI in Drug Discovery Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for AI in Drug Discovery Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How AI in Drug Discovery Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the AI in Drug Discovery Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes Aria Pharmaceuticals Inc, Atomwise Inc, BenevolentAI Ltd, Celsius Therapeutics Inc, Cloud Pharmaceuticals Inc, Deep Genomics Inc, Envisagenics Inc, Exscientia Ltd, Google LLC, Illumina Inc, Insilico Medicine Inc, IQVIA Holdings Inc, Microsoft Corp, NVIDIA Corp, Predictive Oncology Inc, Recursion Pharmaceuticals Inc, Schrödinger Inc, Tempus Labs Inc, Tencent Holdings Ltd, Valo Health LLC, Verge Genomics Inc. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
AI in Drug Discovery Market Scope
Leading Segments
By Offering
Software
Services
By Technology
Machine Learning
Natural Language Processing
Context-aware Processing
Others
By Therapeutic Area
Oncology
Infectious Diseases
Neurology
Metabolic Diseases
Cardiovascular Diseases
Immunology
Others
By Process
Target Identification & Selection
Target Validation
Hit Identification & Prioritization
Hit-to-lead Identification/ Lead generation
Lead Optimization
Candidate Selection & Validation
By End-User
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Research Centers and Academic & Government Institutes
Leading Companies
Aria Pharmaceuticals Inc
Atomwise Inc
BenevolentAI Ltd
Celsius Therapeutics Inc
Cloud Pharmaceuticals Inc
Deep Genomics Inc
Envisagenics Inc
Exscientia Ltd
Google LLC
Illumina Inc
Insilico Medicine Inc
IQVIA Holdings Inc
Microsoft Corp
NVIDIA Corp
Predictive Oncology Inc
Recursion Pharmaceuticals Inc
Schrödinger Inc
Tempus Labs Inc
Tencent Holdings Ltd
Valo Health LLC
Verge Genomics Inc
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report
Table of Contents
196 Pages
- 1. Table of Contents
- List of Figures and Tables
- 2. Executive Summary
- 2.1 Key Highlights
- 2.1.1 AI in Drug Discovery Market Size Outlook, 2018-2024 and 2025-2032
- 2.1.2 Largest AI in Drug Discovery Market Types and Applications
- 2.1.3 Fastest Growing Segments
- 2.1.4 Potential Markets
- 2.1.5 Market Concentration
- 2.2 Market Scope and Segmentation
- 2.2.1 Market Scope- Segments
- 2.2.2 Market Scope- Countries
- 2.2.3 Macroeconomic and Demographic Outlook
- 2.2.4 Abbreviations
- 2.2.5 Units and Currency Conversions
- 3. Research Methodology
- 3.1 Primary Research Surveys
- 3.2 Secondary Data Sources
- 3.3 Data Triangulation
- 3.4 Forecast Methodology
- 3.5 Assumptions and Limitations
- 4. Introduction to Global AI in Drug Discovery Market in 2025
- 4.1 Industry Panorama
- 4.2 Leading Companies Profiled in the Study
- 4.3 Asia Pacific Markets offer Robust Market Prospects for New Entrants
- 4.4 Market Dynamics
- 4.4.1 Market Dynamics- Trends and Drivers
- 4.4.2 Market Dynamics- Opportunities and Challenges
- 4.5 Regional Analysis
- 4.6 Porter’s Five Force Analysis
- 4.6.1 Intensity of Competitive Rivalry
- 4.6.2 Threat of New Entrants
- 4.6.3 Threat of Substitutes
- 4.6.4 Bargaining Power of Buyers
- 4.6.5 Bargaining Power of Suppliers
- 4.7 AI in Drug Discovery Market Industry Value Chain Analysis
- 4.7.1 Stage of Value Chain
- 4.7.2 Key Activities of Companies
- 4.7.3 Companies Included in Each Stage
- 4.7.4 Key Insights
- 5. AI in Drug Discovery Market Outlook to 2032
- 5.1 Market Size Forecast by Type, 2021-2024 and 2025-2032
- 5.2 Market Size Forecast by Application, 2021-2024 and 2024-2032
- 5.3 Market Size Forecast by Geography, 2021-2024 and 2024-2032
- By Offering
- Software
- Services
- By Technology
- Machine Learning
- -Deep Learning
- -Supervised Learning
- -Reinforcement Learning
- -Others
- Natural Language Processing
- Context-aware Processing
- Others
- By Therapeutic Area
- Oncology
- Infectious Diseases
- Neurology
- Metabolic Diseases
- Cardiovascular Diseases
- Immunology
- Others
- By Process
- Target Identification & Selection
- Target Validation
- Hit Identification & Prioritization
- Hit-to-lead Identification/ Lead generation
- Lead Optimization
- Candidate Selection & Validation
- By End-User
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
- Research Centers and Academic & Government Institutes
- 6. Global AI in Drug Discovery Market Outlook across Growth Scenarios
- 6.1 Low Growth Scenario
- 6.2 Base/Reference Case
- 6.3 High Growth Scenario
- 6. North America AI in Drug Discovery Market Size Outlook
- 6.1 Key Market Statistics, 2024
- 6.2 North America AI in Drug Discovery Market Trends and Growth Opportunities
- 6.2.1 North America AI in Drug Discovery Market Outlook by Type
- 6.2.2 North America AI in Drug Discovery Market Outlook by Application
- 6.3 North America AI in Drug Discovery Market Outlook by Country
- 6.3.1 The US AI in Drug Discovery Market Outlook, 2021- 2032
- 6.3.2 Canada AI in Drug Discovery Market Outlook, 2021- 2032
- 6.3.3 Mexico AI in Drug Discovery Market Outlook, 2021- 2032
- 7. Europe AI in Drug Discovery Market Size Outlook
- 7.1 Key Market Statistics, 2024
- 7.2 Europe AI in Drug Discovery Market Trends and Growth Opportunities
- 7.2.1 Europe AI in Drug Discovery Market Outlook by Type
- 7.2.2 Europe AI in Drug Discovery Market Outlook by Application
- 7.3 Europe AI in Drug Discovery Market Outlook by Country
- 7.3.2 Germany AI in Drug Discovery Market Outlook, 2021- 2032
- 7.3.3 France AI in Drug Discovery Market Outlook, 2021- 2032
- 7.3.4 The UK AI in Drug Discovery Market Outlook, 2021- 2032
- 7.3.5 Spain AI in Drug Discovery Market Outlook, 2021- 2032
- 7.3.6 Italy AI in Drug Discovery Market Outlook, 2021- 2032
- 7.3.7 Russia AI in Drug Discovery Market Outlook, 2021- 2032
- 7.3.8 Rest of Europe AI in Drug Discovery Market Outlook, 2021- 2032
- 8. Asia Pacific AI in Drug Discovery Market Size Outlook
- 8.1 Key Market Statistics, 2024
- 8.2 Asia Pacific AI in Drug Discovery Market Trends and Growth Opportunities
- 8.2.1 Asia Pacific AI in Drug Discovery Market Outlook by Type
- 8.2.2 Asia Pacific AI in Drug Discovery Market Outlook by Application
- 8.3 Asia Pacific AI in Drug Discovery Market Outlook by Country
- 8.3.1 China AI in Drug Discovery Market Outlook, 2021- 2032
- 8.3.2 India AI in Drug Discovery Market Outlook, 2021- 2032
- 8.3.3 Japan AI in Drug Discovery Market Outlook, 2021- 2032
- 8.3.4 South Korea AI in Drug Discovery Market Outlook, 2021- 2032
- 8.3.5 Australia AI in Drug Discovery Market Outlook, 2021- 2032
- 8.3.6 South East Asia AI in Drug Discovery Market Outlook, 2021- 2032
- 8.3.7 Rest of Asia Pacific AI in Drug Discovery Market Outlook, 2021- 2032
- 9. South America AI in Drug Discovery Market Size Outlook
- 9.1 Key Market Statistics, 2024
- 9.2 South America AI in Drug Discovery Market Trends and Growth Opportunities
- 9.2.1 South America AI in Drug Discovery Market Outlook by Type
- 9.2.2 South America AI in Drug Discovery Market Outlook by Application
- 9.3 South America AI in Drug Discovery Market Outlook by Country
- 9.3.1 Brazil AI in Drug Discovery Market Outlook, 2021- 2032
- 9.3.2 Argentina AI in Drug Discovery Market Outlook, 2021- 2032
- 9.3.3 Rest of South and Central America AI in Drug Discovery Market Outlook, 2021- 2032
- 10. Middle East and Africa AI in Drug Discovery Market Size Outlook
- 10.1 Key Market Statistics, 2024
- 10.2 Middle East and Africa AI in Drug Discovery Market Trends and Growth Opportunities
- 10.2.1 Middle East and Africa AI in Drug Discovery Market Outlook by Type
- 10.2.2 Middle East and Africa AI in Drug Discovery Market Outlook by Application
- 10.3 Middle East and Africa AI in Drug Discovery Market Outlook by Country
- 10.3.1 Saudi Arabia AI in Drug Discovery Market Outlook, 2021- 2032
- 10.3.2 The UAE AI in Drug Discovery Market Outlook, 2021- 2032
- 10.3.3 Rest of Middle East AI in Drug Discovery Market Outlook, 2021- 2032
- 10.3.4 South Africa AI in Drug Discovery Market Outlook, 2021- 2032
- 10.3.5 Egypt AI in Drug Discovery Market Outlook, 2021- 2032
- 10.3.6 Rest of Africa AI in Drug Discovery Market Outlook, 2021- 2032
- 11. Company Profiles
- 11.1 Leading 10 Companies
- Aria Pharmaceuticals Inc
- Atomwise Inc
- BenevolentAI Ltd
- Celsius Therapeutics Inc
- Cloud Pharmaceuticals Inc
- Deep Genomics Inc
- Envisagenics Inc
- Exscientia Ltd
- Google LLC
- Illumina Inc
- Insilico Medicine Inc
- IQVIA Holdings Inc
- Microsoft Corp
- NVIDIA Corp
- Predictive Oncology Inc
- Recursion Pharmaceuticals Inc
- Schrödinger Inc
- Tempus Labs Inc
- Tencent Holdings Ltd
- Valo Health LLC
- Verge Genomics Inc
- 11.2 Overview
- 11.3 Products and Services
- 11.4 SWOT Profile
- 12. Appendix
- 12.1 Subscription Options
- 12.2 Customization Options
- 12.3 Publisher Details
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
